An updated review of mesoporous carbon as a novel drug delivery system

Faculty Pharmacy Year: 2021
Type of Publication: ZU Hosted Pages: 1029-1037
Authors:
Journal: Drug Development and Industrial Pharmacy Taylor & Francis Volume: 47
Keywords : , updated review , mesoporous carbon , , novel drug    
Abstract:
The nanotechnology approach has been recently adopted to provide more reliable, effective, controlled, and safe drug delivery systems. Nanostructured materials have gained great interest, including siliceous and carbonaceous nanoparticles. The effectiveness of mesoporous carbon nanoparticles (MCNs) in tumor imaging, targeting, and treatment is urging for more future studies. MCNs possess superior properties such as their biocompatibility, large surface area, large pore volume, tunability, and more responsive behavior to internal and external release triggers. These outstanding features make MCNs more applicable for stimuli-responsive drug delivery than the conventional forms of mesoporous silica nanoparticles (MSNs) and other carbon nanoparticles. In this review, we outlined the latest updates regarding the safety, benefits, and potential applications of MCNs.
   
     
 
       

Author Related Publications

    Department Related Publications

    • Ahmed Samer Zedan, "Controlled release of Diclofenac sodium from matrix tablet formulations.", لايوجد, 1900 More
    • Ahmed Samer Zedan, "Process Analytical Technology: Nondestructive Evaluation of Cyclosporine A and Phospholipid Solid Dispersions by Near Infrared Spectroscopy and Chemical Imaging", لايوجد, 1900 More
    • Azza Ali Hassan Solyman, "Design and in vitro characterization of small unilamellar niosomes as ophthalmic carrier of dorzolamide hydrochloride", Informa health, 2014 More
    • Azza Ali Hassan Solyman, "Formulation and Evaluation of Timolol Maleate Loaded Niosomes as an Ocular Drug Delivery System", Bull.Fac.Pham.Cairo Univ., 2004 More
    • Amr Selim Ahmed Ali Abu Lila, "Generation, characterization and in vivo biological activity of two distinct monoclonal anti-PEG IgMs", Elsevier, 2014 More
    Tweet